nitazoxanide has been researched along with montelukast in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Constant, P; Daffé, M; Guillet, V; Le, NH; Marrakchi, H; Maveyraud, L; Mourey, L; Nahoum, V; Tranier, S; Verhaeghe, P | 1 |
1 review(s) available for nitazoxanide and montelukast
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 other study(ies) available for nitazoxanide and montelukast
| Article | Year |
|---|---|
Drug screening approach against mycobacterial fatty acyl-AMP ligase FAAL32 renews the interest of the salicylanilide pharmacophore in the fight against tuberculosis.
Topics: Adenosine Monophosphate; Antitubercular Agents; Drug Evaluation, Preclinical; Humans; Mycobacterium tuberculosis; Salicylanilides; Tuberculosis | 2022 |